Donald Hooker
Stock Analyst at Keybanc
(2.81)
# 1,808
Out of 4,876 analysts
82
Total ratings
55.95%
Success rate
17.03%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $8.41 | +1,089.06% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $150.01 | +159.98% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $177.83 | -4.40% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $157.47 | +84.16% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $28.49 | +156.23% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $5.03 | +615.71% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $7.94 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $283.41 | +24.55% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $104.88 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $69.99 | +20.02% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $11.16 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $260.59 | -34.76% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $144.56 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.49 | +2,987.25% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.61 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $310.69 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $8.41
Upside: +1,089.06%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $150.01
Upside: +159.98%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $177.83
Upside: -4.40%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $157.47
Upside: +84.16%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $28.49
Upside: +156.23%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.03
Upside: +615.71%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $7.94
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $283.41
Upside: +24.55%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $104.88
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $69.99
Upside: +20.02%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $11.16
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $260.59
Upside: -34.76%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $144.56
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.49
Upside: +2,987.25%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $21.61
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $310.69
Upside: -